The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Nanodiagnostics: A New Frontier for Clinical Laboratory Medicine
Abstract
Background: The use of nanotechnologies for diagnostic applications shows great promise to meet the rigorous demands of the clinical laboratory for sensitivity and cost-effectiveness. New nanodiagnostic tools include quantum dots (QDs), gold nanoparticles, and cantilevers. QDs, which are the most promising nanostructures for diagnostic applications, are semiconductor nanocrystals characterized by high photostability, single-wavelength excitation, and size-tunable emission. QDs and magnetic nanoparticles can be used for barcoding of specific analytes. Gold and magnetic nanoparticles are key components of the bio-barcode assay, which has been proposed as a future alternative to the PCR. Methods: We examined articles published over the past 10 years investigating the use of QDs, gold nanoparticles, cantilevers, and other nanotechnologies in promising diagnostic applications. Results: Several nanodiagnostic assays have been developed, including a QD-based assay capable of detecting biotinylated prostate-specific antigen (PSA) at 0.38 ng/L, a bio-barcode assay capable of detecting 30 amol/L PSA in a 10-μL sample, and another able to detect 50 molecules of the Alzheimer marker amyloid β-derived diffusible ligand in 10 μL of cerebrospinal fluid. Conclusions: Nanodiagnostics promise increased sensitivity, multiplexing capabilities, and reduced cost for many diagnostic applications as well as intracellular imaging. Further work is needed to fully optimize these diagnostic nanotechnologies for clinical laboratory setting and to address the potential health and environmental risks related to QDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanostructures in Biodiagnostics
Rosi, N. L., & Mirkin, C. A. (2005) · Chemical Reviews · doi:10.1021/cr030067f · Cited by 4,603
Cited by
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: A review
Pei, X., Zhang, B., Tang, J., Liu, B., Lai, W., & Tang, D. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.10.060 · Cited by 454
Clift, M. J. D., Rothen-Rutishauser, B., Brown, D. M., Duffin, R., Donaldson, K., Proudfoot, L., Guy, K., & Stone, V. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.009 · Cited by 358
Nanobioimaging and sensing of infectious diseases
Tallury, P., Malhotra, A., Byrne, L. M., & Santra, S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.014 · Cited by 301
Determination of Size and Concentration of Gold Nanoparticles from Extinction Spectra
Khlebtsov, N. G. (2008) · Analytical Chemistry · doi:10.1021/ac800834n · Cited by 295
Metadata
- Authors
- Azzazy, H. M., Mansour, M. M., & Kazmierczak, S. C.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1238-1246
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2074967496
- Cited by
- 187
- References
- 1
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanodiagnostics: A New Frontier for Clinical Laboratory Medicine. https://app.cochat.ai/papers/10.1373/clinchem.2006.066654
- The paper
- Azzazy, H. M., Mansour, M. M., & Kazmierczak, S. C. (2006). Nanodiagnostics: A New Frontier for Clinical Laboratory Medicine. Clinical Chemistry. https://doi.org/10.1373/clinchem.2006.066654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.